Genzyme Corporate Research Search Genzyme Websites
PatientsHealth Care ProfessionalsPayors
Thyrogen
Patient Overview
Newly Diagnosed
Follow-up
Reimbursement
Resources
Product Information (PDF)

Thyrogen

Information for Patients

Thyroid cancer is a cancerous tumor or growth in the thyroid gland. Most thyroid cancers can be treated successfully — the overall 5-year survival rate is 96%. Even when therapy is successful, your physician may want you to be tested routinely for recurrence. As many as 30% of thyroid cancers may recur, and one third of recurrences may happen 10 years or more after initial treatment.

Thyroid cancer and the lifelong management it may require can seem confusing — even overwhelming. This section provides insights for thyroid cancer patients, their families and caregivers. Find more information below, depending on whether you’ve just been diagnosed or have had the disease for some time.

For newly diagnosed patients:

  • Learn about thyroid cancer and how it’s diagnosed and managed
  • See what a diagnosis of thyroid cancer might mean for your life

For patients in a follow-up routine:

  • Find out what to expect after your initial treatment
  • Take a look at recurrence statistics
  • Learn about testing practices during follow-up
  • Read about the role of Thyrogen® in your follow-up testing
  • Please see important safety information below.

For ALL patients:

Please see important safety information below.


Safety Information
Thyrogen® (thyrotropin alfa for injection) is used in combination with other tests to detect recurring or leftover thyroid cancer cells in patients with a history of certain types of thyroid cancer. Thyrogen is injected in a muscle, and is available only by prescription. The most common side effects reported in clinical studies were nausea, headache, weakness & vomiting. When using Thyrogen, there is a risk that thyroid cancer cells may not be detected and diagnosis of recurring cancer may be missed. If you think that Thyrogen may be right for you, or if you have any problems with the use of Thyrogen, please contact your doctor. To learn more, please see full product information (PDF), contact Genzyme toll free at 1-88-THYROGEN (1-888-497-6436).
Search Thyrogen
Keyword: 
Search In: 
 
Highlight

Consider the Facts:

Thyroid Cancer is the most common endocrine cancer and occurs in all age groups.

Thyroid Cancer recently was ranked as the #1 cancer in incidence growth in women (National Cancer Institute data).

Thyroid Cancer may recur in up to 30% of patients, even decades after initial diagnosis.

Resources
Related Links
Testing Schedule
Patient Education Materials
Request Materials
Events Calendar
Low-iodine Diet
Glossary
Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
888 497 6436
617 768 8050
Contact Genzyme



 
Thyrogen Terms and Conditions of Use | Privacy Policy | This site is intended for United States residents only © 2003-2008 Genzyme Corporation. All rights reserved. Genzyme